Clinical trial
Use of Peripheral Blood Mononuclear Cells as biOmarkers of diaBetic cardIomyopathy
NCT05651919 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Peripheral Blood Mononuclear Cells as biOmarkers of diaBetic cardIomyopathy
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 23, 2023
- Completion date
- May 23, 2028
- Enrollment
- 175 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure with mildly reduced ejection fraction, heart failure with preserved ejection fraction, metabolic syndrome, type 2 diabetes